Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H20BrNO3 |
| Molecular Weight | 366.25 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CCNCC2=C(O)C=CC=C2)=C(OC)C=C1Br
InChI
InChIKey=RSUNJYKZRKIBNB-UHFFFAOYSA-N
InChI=1S/C17H20BrNO3/c1-21-16-10-14(18)17(22-2)9-12(16)7-8-19-11-13-5-3-4-6-15(13)20/h3-6,9-10,19-20H,7-8,11H2,1-2H3
| Molecular Formula | C17H20BrNO3 |
| Molecular Weight | 366.25 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:15:40 GMT 2023
by
admin
on
Sat Dec 16 10:15:40 GMT 2023
|
| Record UNII |
KHR1SJ9L0Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-25B-NBOH
Created by
admin on Sat Dec 16 10:15:40 GMT 2023 , Edited by admin on Sat Dec 16 10:15:40 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
KHR1SJ9L0Y
Created by
admin on Sat Dec 16 10:15:40 GMT 2023 , Edited by admin on Sat Dec 16 10:15:40 GMT 2023
|
PRIMARY | |||
|
25B-NBOH
Created by
admin on Sat Dec 16 10:15:40 GMT 2023 , Edited by admin on Sat Dec 16 10:15:40 GMT 2023
|
PRIMARY | 25B-NBOH (2C-B-NBOH, NBOH-2C-B) is a derivative of the phenethylamine derived hallucinogen 2C-B which has been sold as a designer drug. It acts as a potent serotonin receptor agonist with similar affinity to the better-known compound 25B-NBOMe at 5-HT2A and 5-HT2C receptors with pKis values of 8.3 and 9.4, respectively. | ||
|
DTXSID40101717
Created by
admin on Sat Dec 16 10:15:40 GMT 2023 , Edited by admin on Sat Dec 16 10:15:40 GMT 2023
|
PRIMARY | |||
|
1335331-46-8
Created by
admin on Sat Dec 16 10:15:40 GMT 2023 , Edited by admin on Sat Dec 16 10:15:40 GMT 2023
|
PRIMARY | |||
|
125181394
Created by
admin on Sat Dec 16 10:15:40 GMT 2023 , Edited by admin on Sat Dec 16 10:15:40 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
